Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "== Target Article == Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy; LM Xu, H Fang, WH Wang, J Jin, SL Wangae; 2013; doi_citing_unknown == Retraction == RETRACTED: Development and Validation of a New Outcome Score in Subglottic Stenosis; Gonfiotti, Alessandro; Jaus, Massimo Osvaldo; Barale, Daniel; Baiguera, Silvia; Polizzi, Leonardo; J; 2012-10-01 ; https://d...") |
(No difference)
|
Latest revision as of 01:49, 7 August 2022
Target Article[edit | edit source]
Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy; LM Xu, H Fang, WH Wang, J Jin, SL Wangae; 2013; doi_citing_unknown
Retraction[edit | edit source]
RETRACTED: Development and Validation of a New Outcome Score in Subglottic Stenosis; Gonfiotti, Alessandro; Jaus, Massimo Osvaldo; Barale, Daniel; Baiguera, Silvia; Polizzi, Leonardo; J; 2012-10-01
Citation piece[edit | edit source]
Note: Open to append information.